Diaceutics PLC (AIM: DXRX)

Diaceutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	16.75	16.67	19.84	19.68	25.26	11.72
Cash & Short-Term Investments	16.75	16.67	19.84	19.68	25.26	11.72
Cash Growth	-6.33%	-16.00%	0.84%	-22.09%	115.49%	465.18%
Accounts Receivable	8.74	9.83	8.37	7	5.34	6.13
Other Receivables	0.95	0.3	2.05	2.92	2.43	0.24
Receivables	9.68	10.13	10.43	9.92	7.78	6.37
Prepaid Expenses	0.8	1.24	0.63	0.43	0.59	0.33
Other Current Assets	-	-	-	0.04	-	-
Total Current Assets	27.23	28.04	30.9	30.06	33.62	18.42
Property, Plant & Equipment	1.8	1.9	2.09	2.13	0.24	0.13
Other Intangible Assets	14.52	15.26	15.04	12.61	8.94	1.38
Long-Term Deferred Tax Assets	1.87	1.14	0.05	0	0.3	0.06
Long-Term Deferred Charges	-	-	0.18	0.22	0.42	2.38
Total Assets	45.43	46.34	48.26	45.01	43.52	22.37
Accounts Payable	0.61	1.07	0.76	0.51	0.47	0.29
Accrued Expenses	3.14	2.26	2	1.31	1.58	1.45
Short-Term Debt	-	-	-	0.13	0.12	0.11
Current Portion of Leases	0.15	0.15	0.12	0.15	-	-
Current Income Taxes Payable	0.59	0.47	0.42	0.33	0.45	-
Current Unearned Revenue	1.08	0.41	0.41	0.21	0.3	0.39
Other Current Liabilities	0.05	0.04	0.04	-	-	-
Total Current Liabilities	5.61	4.38	3.75	2.63	2.92	2.24
Long-Term Leases	0.98	1.06	1.21	1.29	-	-
Long-Term Deferred Tax Liabilities	-	0.03	0.71	0.45	0.37	-
Other Long-Term Liabilities	0.09	0.09	0.08	-	-	-
Total Liabilities	6.69	5.56	5.74	4.36	3.28	2.24
Common Stock	0.17	0.17	0.17	0.17	0.17	0.14
Additional Paid-In Capital	37.26	37.13	37.13	36.86	36.86	17.34
Retained Earnings	1.87	4.04	5.34	4.08	3.19	2.64
Treasury Stock	-0.31	-0.31	-0.26	-0.17	-	-
Comprehensive Income & Other	-0.25	-0.24	0.14	-0.3	0.02	0.02
Shareholders' Equity	38.74	40.79	42.51	40.65	40.24	20.13
Total Liabilities & Equity	45.43	46.34	48.26	45.01	43.52	22.37
Total Debt	1.13	1.21	1.33	1.56	0.12	0.11
Net Cash (Debt)	15.62	15.46	18.51	18.11	25.14	11.61
Net Cash Growth	-6.05%	-16.48%	2.20%	-27.94%	116.47%	-
Net Cash Per Share	0.19	0.18	0.22	0.21	0.32	0.18
Filing Date Shares Outstanding	84.47	84.25	84.26	83.94	84.07	69.58
Total Common Shares Outstanding	84.47	84.25	84.26	83.94	84.07	69.58
Working Capital	21.62	23.66	27.14	27.43	30.7	16.18
Book Value Per Share	0.46	0.48	0.50	0.48	0.48	0.29
Tangible Book Value	24.22	25.52	27.47	28.04	31.3	18.75
Tangible Book Value Per Share	0.29	0.30	0.33	0.33	0.37	0.27
Machinery	0.79	0.73	0.62	0.48	0.4	0.26
Leasehold Improvements	0.53	0.53	0.53	0.48	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.